microdosing a glp-1 Drugs: What To Know Microdosing GLP-1 Medications in Charleston

E11.9 with Z79.4: Type 2 diabetes, uncontrolled or unspecified, patient on long-term insulin E11.65 with Z79.4: Type 2 diabetes with hyperglycemia, patient on long-term insulin E11.649 with Z79.4: Type 2 diabetes with hypoglycemia without coma, patient on long-term insulin E11.40 with Z79.4: Type 2 diabetes with diabetic neuropathy, patient on long-term insulin Z79.4 is sequenced after the primary E11 combination code

These medications mimic the activity of natural hormone glucagon-like peptide-1 (GLP-1) receptors located in the pancreas, brain, and gut to slow gastric emptying, increase insulin secretion, reduce appetite, and improve blood glucose levels

A Type 2 diabetic patient on insulin has a higher risk profile than one managed by diet or oral agents alone

Audit Alert Z89 acquired absence codes are never the principal diagnosis for an inpatient admission unless the sole reason for admission is prosthetic fitting/adjustment